Pancreatic

A232402CD

PAGODA: RANDOMIZED TRIAL OF A PROACTIVE GRADUATED DOSE MODIFICATION ALGORITHM FOR FOLFOX CHEMOTHERAPY TO PREVENT UNPLANNED DELAYS

NRG GI011 (JIT – IF A POSSIBLE PATIENT IS IDENTIFIED, NOTIFY CRA ASAP AS IT WILL TAKE TIME TO OPEN TRIAL THROUGH NCORP)

A Phase III Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC)

S2408 (MBMC Only)

A Randomized Phase III Blinded Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula

NRG CC014 (XRT at MBMC Only)

Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT)

EAQ222CD *NON-METASTATIC COHORT CLOSED TO ACCRUAL EFFECTIVE 1/13/26**

Effectiveness of Out-of-Pocket Cost COMmunication and Financial Navigation (CostCOM) in Cancer Patients

EAY191-N5 (JIT – IF A POSSIBLE PATIENT IS IDENTIFIED, NOTIFY CRA ASAP AS IT WILL TAKE TIME TO OPEN TRIAL THROUGH NCORP)

A Randomized Trial of Neratinib, a Pan-ERBB Inhibitor, Alone or in Combination with Palbociclib, a CDK4/6 Inhibitor, in Patients with HER2+ Gynecologic Cancers and Other Solid Tumors. A ComboMATCH Treatment Trial

EAY191-E5 COHORT 1 CLOSED TO ACCRUAL EFFECTIVE SEPTEMBER 12, 2025 (JIT – IF A POSSIBLE PATIENT IS IDENTIFIED, NOTIFY CRA ASAP AS IT WILL TAKE TIME TO OPEN TRIAL THROUGH NCORP)

A Randomized Phase II Study of AMG 510 (Sotorasib) with or without Panitumumab in Advanced Solid Tumors: A ComboMATCH Treatment Trial

Clinical Trials

Quick Links